Provider Alert! Coverage of Commercialized COVID-19 Vaccines Begins as a Pharmacy Benefit
Effective Dates: As of September 11, 2023 & October 3, 2023
Date: December 4, 2023
Attention: All Providers
Call to action: Texas Children’s Health Plan (TCHP) would like to inform providers that effective for dates of service on or after September 11, 2023 and October 3, 2023, the U.S. Food and Drug Administration’s (FDA) issued approval and Emergency Use Authorization (EUA) for the following COVID-19 vaccines:
- As of September 11, 2023:
- 2023-2024 Pfizer-BioNTech COVID-19 Vaccine
- 2023-2024 Moderna COVID-19 Vaccine
- As of October 3, 2023:
- 2023-2024 Novavax COVID-19 Vaccine
The new commercialized vaccines include a monovalent (single) component corresponding with the Omicron variant XBB.1.5. Unlike previous doses provided at no cost, commercialized COVID-19 vaccines are for purchase.
Resources:
Next step for providers: Providers should share this communication with their staff.
If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org.
For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.
